Search
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 241 - 255 of 528 items.
Bacitracin for Injection (50,000 IU per vial) and the Risk of Nephrotoxicity and Anaphylactic Reactions
AlertHealth professional risk communication | 2020-12-21
Authorization of Bamlanivimab with English-only Labels for Use in Relation to the COVID-19 Pandemic
AlertHealth professional risk communication | 2020-12-18
Health Canada warns Canadians not to buy COVID-19 vaccines sold online or from unauthorized sources
AlertPublic advisory | 2020-12-16
ELMIRON (pentosan polysulfate sodium) and the Risk of Pigmentary Maculopathy
AlertHealth professional risk communication | 2020-12-15
Pfizer-BioNTech COVID-19 vaccine: Health Canada recommendations for people with serious allergies
AlertPublic advisory | 2020-12-12
Authorization of Pfizer-BioNTech COVID-19 Vaccine with English-only Carton and Vial Labels
AlertHealth professional risk communication | 2020-12-12
Importation of US-labelled Dexrazoxane for Injection distributed by Mylan Pharmaceuticals ULC due to shortage of Canadian-labelled Dexrazoxane
AlertHealth professional risk communication | 2020-12-01
Unauthorized products may pose serious health risks (November 25, 2020)
AlertPublic advisory | 2020-11-25
Ultraviolet (UV) lights and wands falsely claiming to disinfect against COVID-19
AlertPublic advisory | 2020-11-18
Unlicensed soft-shelled hyperbaric chambers may pose serious health risks
AlertPublic advisory | 2020-11-06
Unauthorized nicotine buccal pouches may pose serious health risks
AlertPublic advisory | 2020-11-02
Updates to safety labelling for benzodiazepines and benzodiazepine-like drugs
AlertPublic advisory | 2020-10-30
Recalls of Regener-Eyes Ophthalmic Solution and Regener-Eyes Ophthalmic Solution Lite
AlertPublic advisory | 2020-10-30